On the other hand, PCV eyes were treated with a mean ± SD of 8.1 ± 4.2 anti-VEGF injections during the follow-up, which was not significantly different from n-AMD eyes (p = 0.77). This evidence concerns the gene VEGFA and age-related macular degeneration.